Answers are grounded in this paper and cite their sources.
Background: Cardiorespiratory fitness is a strong predictor of life expectancy and all-cause mortality. Patients with chronic rhinosinusitis with nasal polyps (CRSwNP) often experience reduced physical activity levels due to nasal obstruction and high disease burden. Objective: To evaluate whether mepolizumab, with or without sinus surgery, is associated with changes in habitual physical activity and cardiorespiratory fitness. Methods: max/kg), and disease burden were assessed at baseline and follow-up. Conclusion: Mepolizumab was associated with improvement in physical activity, fitness, and quality of life. FESS provided additional quality-of-life benefits but did not further enhance fitness outcomes.
No takes yet. Share an insight, caveat, or question.
Jens et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: